Stryker has elected Allan C. Golston to become the tenth director as part of its board of directors effective Jan. 2, 2011, according to a company news release.
Spinal Tech
Stryker has increased its dividend by 20 percent and authorized the company to repurchase an additional $500 million of its stock, according to a company news release.
The U.S. Attorney's Office for the Western District of New York issued a subpoena to Medtronic seeking information about the company's neurostimulation products, according to a Wall Street Journal report.
Competition will intensify for the $740 million minimally invasive spinal fusion market over the next few years as more companies challenge industry leaders NuVasive and Medtronic Spinal & Biologics, according to a Millennium Research Group report.
Exactech, a Gainesville, Fla.-based orthopedic implant maker, has agreed to pay $3 million and enter into a deferred prosecution agreement with federal prosecutors for to settle allegations it paid kickbacks to physicians, according to a Mass Device report.
The incoming GOP chair of the House Oversight and Reform committee is considering directing CMS to assess the cost effectiveness of medical devices, alleging unnecessary use of orthopedic implants, according to a report by the Wall Street Journal.
Wright Medical Group has launched a limited release of the PRO-TOE VO hammertoe fixation system for patients requiring the fusion of lesser toes for hammertoe deformity, according to a company news release.
Small Bone Innovations has sold its shoulder-related assets to Fx Solutions of Rue de Majornas, a French company that is focused on providing treatment solutions for shoulder fractures and trauma and will market the newly acquired assets, according to a…
Pretrial proceedings in federal lawsuits against Johnson & Johnson over the DePuy ASR XL Acetabular System recall have been consolidated and will be overseen by a federal judge in Ohio, according to a Bloomberg Businessweek news report.
Stryker has entered into a definitive agreement with Olympus Corp. for the $60 million sale of its OP-1 products for use in orthopedic bone applications, according to a Stryker news release.
